(Q71827356)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7594063%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

title

Propionyl-L-carnitine in intermittent claudication: double-blind, placebo-controlled, dose titration, multicenter study (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7594063%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

Propionyl-l-carnitine in intermittent claudication: Double-blind, placebo-controlled, dose titration, multicenter study (English)

1 reference

https://api.crossref.org/works/10.1016/0735-1097(95)00344-4

2 June 2024

1 reference

intermittent claudication

1 reference

1 reference

G. Brevetti

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7594063

2 June 2024

S. Perna

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7594063

2 June 2024

C. Sabbá

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7594063

2 June 2024

V. D. Martone

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7594063

2 June 2024

M. Condorelli

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7594063

2 June 2024

language of work or name

English

0 references

publication date

1 November 1995

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7594063%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

15 November 1995

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=7594063

full work available at URL

2 June 2024

https://api.elsevier.com/content/article/PII:0735109795003444?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/0735-1097(95)00344-4

https://api.elsevier.com/content/article/PII:0735109795003444?httpAccept=text/plain

2 June 2024

1 reference

https://api.crossref.org/works/10.1016/0735-1097(95)00344-4

Journal of the American College of Cardiology

2 June 2024

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7594063%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

volume

26

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7594063%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

issue

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7594063%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

page(s)

1411-1416

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7594063%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

cites work

2

1 reference

https://api.crossref.org/works/10.1016/0735-1097(95)00344-4

Pentoxifylline efficacy in the treatment of intermittent claudication: multicenter controlled double-blind trial with objective assessment of chronic occlusive arterial disease patients

2 June 2024

3

1 reference

https://api.crossref.org/works/10.1016/0735-1097(95)00344-4

Does oxpentifylline (‘Trental’) have a place in the treatment of intermittent claudication?

2 June 2024

4

1 reference

https://api.crossref.org/works/10.1016/0735-1097(95)00344-4

Drug treatment of intermittent claudication: a critical analysis of the methods and findings of published clinical trials, 1965-1985.

2 June 2024

6

1 reference

https://api.crossref.org/works/10.1016/0735-1097(95)00344-4

Conservative drug treatment in patients with moderately severe chronic occlusive peripheral arterial disease. Scandinavian Study Group

2 June 2024

7

1 reference

https://api.crossref.org/works/10.1016/0735-1097(95)00344-4

Randomized placebo-controlled, double-blind trial of ketanserin in claudicants. Changes in claudication distance and ankle systolic pressure. PACK Claudication Substudy

2 June 2024

9

1 reference

https://api.crossref.org/works/10.1016/0735-1097(95)00344-4

Effect of physical training on different categories of patients with intermittent claudication

2 June 2024

11

1 reference

https://api.crossref.org/works/10.1016/0735-1097(95)00344-4

Benefit of exercise conditioning for patients with peripheral arterial disease

2 June 2024

12

1 reference

https://api.crossref.org/works/10.1016/0735-1097(95)00344-4

Carnitine--metabolism and functions

2 June 2024

13

1 reference

https://api.crossref.org/works/10.1016/0735-1097(95)00344-4

Carnitine deficiency of skeletal muscle: report of a treated case

2 June 2024

14

1 reference

https://api.crossref.org/works/10.1016/0735-1097(95)00344-4

Muscle carnitine deficiency in patients with severe peripheral vascular disease

2 June 2024

16

1 reference

https://api.crossref.org/works/10.1016/0735-1097(95)00344-4

Skeletal muscle carnitine metabolism in patients with unilateral peripheral arterial disease

2 June 2024

17

1 reference

https://api.crossref.org/works/10.1016/0735-1097(95)00344-4

Increases in walking distance in patients with peripheral vascular disease treated with L-carnitine: a double-blind, cross-over study

2 June 2024

18

1 reference

https://api.crossref.org/works/10.1016/0735-1097(95)00344-4

Propionyl-L-carnitine: biochemical significance and possible role in cardiac metabolism

2 June 2024

19

1 reference

https://api.crossref.org/works/10.1016/0735-1097(95)00344-4

Superiority of L-propionylcarnitine vs L-carnitine in improving walking capacity in patients with peripheral vascular disease: an acute, intravenous, double-blind, cross-over study

2 June 2024

20

1 reference

https://api.crossref.org/works/10.1016/0735-1097(95)00344-4

2 June 2024

A question of control

21

1 reference

https://api.crossref.org/works/10.1016/0735-1097(95)00344-4

The analysis of a titration study

2 June 2024

22

1 reference

https://api.crossref.org/works/10.1016/0735-1097(95)00344-4

The analysis of titration studies in phase III clinical trials.

2 June 2024

23

1 reference

https://api.crossref.org/works/10.1016/0735-1097(95)00344-4

Another look at the pentoxifylline efficacy data for intermittent claudication

2 June 2024

24

1 reference

https://api.crossref.org/works/10.1016/0735-1097(95)00344-4

Conservative management of intermittent claudication

2 June 2024

25

1 reference

https://api.crossref.org/works/10.1016/0735-1097(95)00344-4

Intermittent claudication: a double-blind crossover trial of pentoxifylline

2 June 2024

28

1 reference

https://api.crossref.org/works/10.1016/0735-1097(95)00344-4

Quinapril--a new angiotensin-converting enzyme inhibitor: an overview

2 June 2024

29

1 reference

https://api.crossref.org/works/10.1016/0735-1097(95)00344-4

The determination of practically useful doses of new drugs: some methodological considerations

2 June 2024

30

1 reference

https://api.crossref.org/works/10.1016/0735-1097(95)00344-4

Pyruvate carboxylase and propionyl-CoA carboxylase as anaplerotic enzymes in skeletal muscle mitochondria

2 June 2024

34

1 reference

https://api.crossref.org/works/10.1016/0735-1097(95)00344-4

Anaplerotic effect of propionyl carnitine in rat heart mitochondria

2 June 2024

35

1 reference

https://api.crossref.org/works/10.1016/0735-1097(95)00344-4

Effect of propionyl-L-carnitine in a rat model of peripheral arteriopathy: A functional, histologic, and NMR spectroscopic study

2 June 2024

36

1 reference

https://api.crossref.org/works/10.1016/0735-1097(95)00344-4

2 June 2024

Identifiers

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7594063%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

1 reference